Danaher (DHR) | Stock Overview & Key Data
Danaher Performance Comparison
Stock Range
Today's Range
Low: $209.83
High: $212.40
on August 15, 2025
52 Week Range
Low: $171.00
High: $279.90
on April 9, 2025
on September 26, 2024
All-Time High: $296.06 on September 6, 2021
Explore how other US stocks compare to their 52-week ranges: View US Market 52-Week Insights
Key Statistics
Market Cap
$151.0B
EPS
4.70
P/E Ratio (TTM)
44.88
Forward P/E
25.17
P/B Ratio
2.89
PEG Ratio
-1.20
Div. Yield
N/A
ROE
6.68%
Beta
0.761
Debt to Equity
35.45
Financial Highlights
Profitability
Gross Margin
59.35%
Operating Margin
20.12%
Profit Margin
14.21%
Returns and Earnings
Return on Assets (TTM)
4.01%
Return on Equity (TTM)
6.68%
EBITDA
$6.8B
Net Income (TTM)
$3.4B
Growth
Revenue (TTM)
Revenue Per Share (TTM)
$33.39
Quarterly Revenue Growth (YoY)
3.40%
Quarterly Earnings Growth (YoY)
-38.80%
Peer Performance Comparison
| Company | Market Cap | 1W | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|---|---|---|
| Danaher DHR | 151.04B Large-cap | 5.17% | 9.37% | 10.46% | 3.13% | -8.22% | -21.68% | -18.64% | 14.50% |
| Thermo Fisher TMO | 184.66B Large-cap | 6.14% | 16.99% | 20.76% | -6.52% | -6.42% | -19.04% | -16.91% | 14.10% |
| Idexx Laboratories IDXX | 52.07B Large-cap | -1.10% | 23.58% | 27.12% | 44.93% | 59.19% | 32.21% | 74.14% | 69.73% |
| Agilent Technologies A | 33.86B Large-cap | 4.00% | 5.54% | 6.05% | -11.83% | -10.66% | -14.88% | -13.38% | 21.26% |
| Iqvia Holdings IQV | 32.49B Large-cap | 6.24% | 21.19% | 36.07% | -1.07% | -2.07% | -20.26% | -20.05% | 21.27% |
| Mettler-Toledo MTD | 27.03B Large-cap | 4.49% | 12.30% | 14.78% | 3.08% | 7.50% | -7.42% | -1.61% | 36.70% |
Ownership & Short Interest
Insider Ownership
11.05%
Institutional Ownership
82.68%
Shares Short
8M
Short Ratio
1.93
Short % of Shares Outstanding
1.33%
Average 10-Day Volume
3M
Average 90-Day Volume
4M
Danaher Recurring Investment / Dollar-Cost Averaging Calculator
Calculate how a regular investment in Danaher would have performed over time.
Note: This calculator is for informational purposes only and does not consider taxes, fees, or other costs associated with investing.
Frequently Asked Questions
- What is DHR's 52-week high and low?
- In the last 52 weeks, Danaher reached a high of $279.90 (on September 26, 2024) and a low of $171.00 (on April 9, 2025).
- What is the market cap and P/E ratio for DHR?
- Curious about Danaher's size and valuation? Its market capitalization stands at 151.04B. When it comes to valuation, the P/E ratio (trailing twelve months) is 44.88, and the forward P/E (looking ahead) is 25.17.
- Does DHR pay dividends? If so, what's the yield?
- As for dividends, Danaher isn't currently offering a significant yield, or that specific data isn't available right now.
- Who are Danaher's main competitors or similar companies to consider before investing?
When looking at Danaher, it can be helpful to see how it compares to other players in its field. Here are a few similar companies or key competitors:
Company Mkt Cap Sector Industry 1Y Return 3Y Return Thermo Fisher
TMO184.66B Healthcare Diagnostics & Research -19.04% -16.91% Idexx Laboratories
IDXX52.07B Healthcare Diagnostics & Research 32.21% 74.14% Agilent Technologies
A33.86B Healthcare Diagnostics & Research -14.88% -13.38% Iqvia Holdings
IQV32.49B Healthcare Diagnostics & Research -20.26% -20.05% Mettler-Toledo
MTD27.03B Healthcare Diagnostics & Research -7.42% -1.61% For a more comprehensive list, please see the Peer Performance Comparison table on this page.
- What are the key financial health indicators for Danaher Corporation? (e.g., ROE, Debt/Equity)
- To get a sense of Danaher's financial health, here are a few key indicators: its Return on Equity (ROE) over the last twelve months is 6.68%, the Debt to Equity ratio from the most recent quarter is 35.45, and its Gross Profit Margin stands at 59.35%.
- What is the recent revenue and earnings growth for DHR?
- Looking at Danaher's growth, its revenue over the trailing twelve months (TTM) was $24B. Compared to the same quarter last year (YoY), quarterly revenue grew by 3.40%, and quarterly earnings saw a YoY growth of -38.80%.
- How much of DHR stock is held by insiders and institutions?
- Wondering who owns Danaher stock? Company insiders (like executives and directors) hold about 11.05% of the shares, while institutional investors (such as mutual funds and pension funds) own approximately 82.68%.
For more common questions about our data, please visit our About Data page.
Data is provided for informational purposes only. Devyara does not guarantee the accuracy of the data displayed.